Written by Steven Hansen
The U.S. new cases 7-day rolling average are 12.1 % HIGHER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 19.4 % LOWER than the rolling average one week ago. Today’s posts include:
- U.S. Coronavirus New Cases are 75,724
- U.S. Coronavirus deaths are at 1,260
- U.S. Coronavirus immunizations have been administered to 39.9 % of the population
- The 7-day rolling average rate of growth of the pandemic shows new cases worsened and deaths improved [new cases are now clearly on a worsening trend]
- Universal mask policy could reduce healthcare workers’ risk of acquiring COVID-19
- More than two in five American adults reported recent symptoms of an anxiety or depressive disorder.
- NIAID Launches Trial to Assess Post-Vax COVID Transmission Risk
- When Will IRS Send Third Stimulus Payments to Social Security Recipients?
- Cancer drug lessens the toxicity of a protein from COVID-19 virus
- Quality Sleep Extremely Elusive for Most During Pandemic, Survey Shows
- Eli Lilly antibody treatment stopped due to spread of COVID-19 variants
- The C.D.C.’s ex-director offers no evidence in favoring speculation that the coronavirus originated in a lab.
- Could an accident have caused COVID-19? Why the Wuhan lab-leak theory shouldn’t be dismissed
include($_SERVER[‘DOCUMENT_ROOT’].’/pages/coronavirus1.htm’); ?>
Hospitalizations Are The Only Accurate Gauge
Hospitalizations historically appear to be little affected by weekends or holidays. The hospitalization growth rate trend is improving.
source: https://gis.cdc.gov/grasp/covidnet/COVID19_3.html
Historically, hospitalization growth follows new case growth by one to two weeks.
As an analyst, I use the rate of growth to determine the trend. But, the size of the pandemic is growing in terms of real numbers – and if the rate of growth does not become negative – the pandemic will overwhelm all resources.
The graph below shows the rate of growth relative to the growth a week earlier updated through today [note that negative numbers mean the rolling averages are LOWER than the rolling averages one week ago]. As one can see, the rate of growth for new cases peaked in early December 2020 for Thanksgiving, and early January 2021 for end of year holidays – and it now shows that the coronavirus effect is now shrinking.
In the scheme of things, new cases decline first, followed by hospitalizations, and then deaths.
Will The New Variants Cause The Next Spike?
Maybe and maybe not. It all depends on vaccinations:
- the more people that are vaccinated reduces the pool of people that can be infected. Today we have removed over 39 % of the population from being infected which theoretically should reduce the infection rate by 39 % [it is unproven whether the vaccines prevent a vaccinated person from being a carrier of the virus even though showing no signs]. If the vaccines are shown to stop transmission, then in theory it would reduce the infection rate by double the percent vaccinated [in this case you prevent your own infection and do not pass it along to another].
- it is also unknown what the effective rate of the current vaccines is against mutations that seem to appear almost daily. As an example, if the effective rate drops to 60%, it means the 39 % reduction in the infection rate discussed above is almost cut in half. The South African and Brazilian variant is reported somewhat immune to the current vaccines.
- The pandemic should be over immediately if everyone could be vaccinated today. The problem is that every day brings a new mutation (which would not appear if the pandemic was stopped). The longer the immunization process takes – the more ineffective the vaccine will become.
- It is not clear whether the vaccine prevents those vaccinated from spreading the virus. It seems to be well documented that it normally stops the virus from taking hold and when it does not – the infection is mild.
Coronavirus News You May Have Missed
Disregard for public health measures from spring breakers and pandemic-weary tourists in South Florida will likely result in a spike of COVID-19 cases, health experts say.
Modeling suggests there’s going to be a “bump” in the curve, according to Dr. David Andrews, associate professor at the University of Miami Miller School of Medicine and vice chair for pathology laboratories at Jackson Health System.
“Everyone is concerned, and the University of Miami epidemiologists have projected a surge to emerge from that activity post-spring break,” he said. “They’re predicting a bump in the next couple of weeks.”
Although some Floridians and out-of-town vacationers may have immunity from prior infection or the vaccines, what worries experts most is the highly transmissible coronavirus variant B.1.1.7 is quickly becoming the dominant variant in Florida.
The B.1.1.7 variant, first identified in the U.K., accounts for about 50% of the positive cases sampled at Jackson Health, Andrews said. Experts say it could outpace the speed of vaccinations.
In addition to this threat, experts are keep an eye out for the B.1.526 variant that could be brought in from New York. This variant popped up in New York City in late November and has since cropped up in neighboring states.
[editor’s note: also read Expected Spring Break-Related COVID-19 Surge Reported at Some Colleges]
More than two in five American adults reported recent symptoms of an anxiety or depressive disorder. – New York Times
The number of American adults reporting recent bouts of anxiety or depression rose significantly between August and February, increasing to more than two in five adults in late January, federal health researchers said on Friday.
The largest increases were among young adults and those who never finished high school, but every demographic group — including all racial and ethnic groups, genders and ages — experienced some increase in symptoms, said Anjel Vahratian, an associate director at the National Center for Health Statistics and the report’s lead author.
Among adults aged 18 to 29, the percentage who reported having anxiety or depressive symptoms in the previous week increased to 57 percent in late January, up from 49 percent in August 2020. About half of respondents without a high school diploma reported symptoms recently, up from 41.8 percent in August. Overall, 41.4 percent of all adults reported symptoms in late January and early February, up from 36.4 percent in August.
Men and women reported more symptoms, as did adults in their 30s and adults in their 60s, who saw statistically significant increases.
Dr. Vahratian said she was surprised by the magnitude of the increases. Though the study does not prove the problems were caused by the pandemic, previous studies have shown a link between large disease outbreaks and mental health, she noted.
“You have extended social restrictions, limits on businesses, isolation and issues with employment — these have all been associated with increases in mental health problems,” Dr. Vahratian said. “We can’t speak to the direct causes because the survey didn’t ask about the cause of the symptoms. But it suggests that a variety of things going on during the pandemic are involved.”
When Will IRS Send Third Stimulus Payments to Social Security Recipients? – Newsweek
Recipients of Social Security, Supplemental Security Income and other federal benefits could receive their stimulus checks soon after the Social Security Administration (SSA) provided the Internal Revenue Service (IRS) with the necessary paperwork.
The $1,400 payments to some 30 million Americans had been delayed due to a dispute between the SSA and the IRS. However, the House Ways and Means Committee has urged the agencies to expedite distribution of the checks.
The SSA provided the necessary paperwork to the IRS on Thursday—two weeks after the $1.9 trillion American Rescue Plan was passed by Congress—clearing the way for payments to be made.
Democrats on the Ways and Means Committee placed the blame on SSA Commissioner Andrew Saul, who was appointed by former President Donald Trump.
They said the delays “defied congressional intent and imposed needless anxiety and pain on taxpayers.”
On Wednesday, Ways and Means demanded that the SSA hand over the paperwork within 24 hours and the agency complied.
The committee noted in its letter that “the IRS asked SSA to start sending payment files two weeks before the American Rescue Plan became law on March 11, 2021.”
However, SSA Commissioner Saul said in a statement that his agency was “not authorized to substantively engage [the] Treasury or IRS prior to the ARP’s passage.”
NIAID Launches Trial to Assess Post-Vax COVID Transmission Risk – MedPage
Thousands of college students participating in a new trial called PreventCOVIDU will help determine how well COVID-19 vaccines diminish risk of transmitting the infection, officials said Friday.
That the vaccines are highly effective at preventing symptomatic illness is well established.
“But the prevailing question is, when these people get infected, how often is that, if they’re asymptomatic, how much virus do they have in their nose?” said Anthony Fauci, MD, President Biden’s chief medical advisor and director of the National Institute of Allergy and Infectious Diseases, during a White House briefing. “And do they transmit it to people who are their close contacts?”
The open-label randomized trial, which began on Thursday, will test whether vaccine prevents both infection and transmission of SARS-CoV-2 among college students, and will “help inform science-based decisions about mask use and about social distancing post-vaccination,” Fauci added.
The NIH-funded study will include 12,000 college students ages 18 to 26 from more than 20 universities, and is expected to last 5 months, Fauci said. One group of 6,000 students will receive their first dose of the Moderna vaccine immediately. The others will serve as controls and will receive their vaccine 4 months later.
All participants will ultimately receive the usual two doses.
Cancer drug lessens the toxicity of a protein from COVID-19 virus – EurekAlert
University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2–the virus that causes COVID-19 – and then used an FDA-approved cancer drug to blunt the viral protein’s detrimental effects. In their experiments in fruit flies and human cell lines, the team discovered the cell process that the virus hijacks, illuminating new potential candidate drugs that could be tested for treating severe COVID-19 disease patients. Their findings were published in two studies simultaneously on March XX in Cell & Bioscience, a Springer Nature journal.
“Our work suggests there is a way to prevent SARS-COV-2 from injuring the body’s tissues and doing extensive damage,” says senior author of the study Zhe “Zion” Han, PhD, Associate Professor of Medicine and Director of the Center for Precision Disease Modeling at UMSOM. He notes that the most effective drug against Covid-19, remdesivir, only prevents the virus from making more copies of itself, but it does not protect already infected cells from damage caused by the viral proteins.
Prior to the pandemic, Dr. Han had been using fruit flies as a model to study other viruses, such as HIV and Zika. He says his research group shifted gears in February 2020 to study SARS-COV-2 when it was clear that the pandemic was going to significantly impact the U.S.
SARS-COV-2 infects cells and hijacks them into making proteins from each of its 27 genes. Dr. Han’s team introduced each of these 27 SARS-CoV-2 genes in human cells and examined their toxicity. They also generated 12 fruit fly lines to express SARS-CoV-2 proteins likely to cause toxicity based on their structure and predicted function.
The researchers found that a viral protein, known as Orf6, was the most toxic killing about half of the human cells. Two other proteins (Nsp6 and Orf7a) also proved toxic, killing about 30-40 percent of the human cells. Fruit flies that made any one of these three toxic viral proteins in their bodies were less likely to survive to adulthood. Those fruit flies that did live had problems like fewer branches in their lungs or fewer energy-generating power factories in their muscle cells.
Universal mask policy could reduce healthcare workers’ risk of acquiring COVID-19 – News-Medical
A study published in the Journal of Occupational and Environmental Medicine from researchers at Henry Ford Health System has found that Henry Ford’s early implementation of a universal mask policy in the COVID-19 pandemic was associated with reducing the risk of healthcare workers at Henry Ford acquiring COVID-19.
Through retrospective analysis of an internal hospital quality metric reporting analytics database that was not associated with electronic medical records, researchers discovered a correlation between the implementation of Henry Ford’s universal mask policy and a significant drop in the rate at which its Healthcare workers tested positive for SARS-CoV-2. As COVID-19 diagnoses and hospitalizations across the State of Michigan continued to rise through late March 2020, the cases among Henry Ford’s healthcare workers began to fall. By the time the first peak in COVID-19 cases occurred in the general population, the rate of cases among Henry Ford healthcare workers was already trending downward.
This research reinforces the fact that mask wearing is effective in reducing the risk of acquiring COVID-19 and validated our decision early on to implement the universal mask policy, not only to protect our team members, but also to ensure they are able to care for members of the community who had contracted COVID-19. At Henry Ford Health System, our universal mask policy issued on March 26, 2020 ensured all staff, both clinical and non-clinical, received surgical or procedural masks and mandated that staff wear a mask at work while also following all other personal protective equipment requirements. Our hope is that the findings of this study continue to encourage members of the community to wear a mask in line with Centers for Disease Control and Prevention recommendations.”
Steven Kalkanis, M.D., CEO of Henry Ford Medical Group
Healthcare workers have a threefold increased risk of reporting testing positive for SARS-CoV-2, the virus that causes COVID-19, compared to the general population, according to a study published in Lancet Public Health. As of March 22, 2021, the Centers for Disease Control and Prevention (CDC) has reported more than 450,000 SARS-CoV-2 infections among healthcare workers in the U.S. since the onset of the pandemic, and nearly 1,500 COVID-19 related deaths among healthcare workers.
Quality Sleep Extremely Elusive for Most During Pandemic, Survey Shows – Medscape
Fewer than 1 in 10 people report they are getting “very good sleep” at night — just one of several eye-opening findings about the state of sleep quality during the COVID-19 pandemic in new data from University College London researchers.
In a survey of more than 70,000 people, only 7.7% now report their sleep as “very good,” for example, down from 39.4% in March 2020.
Many factors could be driving this drop in sleep quality. Lead author Daisy Fancourt, PhD, and colleagues found people with lower household incomes, with a mental or physical health condition, with lower levels of education, and those from ethnic minority backgrounds were more likely to report “very poor” sleep quality.
“This could be due to a wide range of factors, such as disruption to routines and the changes in living circumstances that lockdown has caused,” co-author Elise Paul, PhD, UCL senior research fellow in Epidemiology & Health Care, stated in a news release.
“Stress is also likely to be a factor,” she added, particularly for people living with lower household incomes or in other challenging circumstances.
Possible protective factors include age greater than 60 years, male sex, and absence of children in the home, according to the weekly report posted online March 25 by UCL COVID-19 Social Study Investigators.
Stress around unemployment and finances was higher among those living with children, they noted.
The proportion of people reporting “very poor sleep” varied over time, almost doubling from 5.4% in autumn 2020 to 10.1% in January 2021, for example. Although the proportion dropped somewhat since the beginning of this year, it remains at approximately the same level it was last summer.
Eli Lilly antibody treatment stopped due to spread of COVID-19 variants – The Hill
The U.S. government has stopped the use of Eli Lilly’s COVID-19 monoclonal antibody treatments due to the spread of COVID-19 variants.
The announcement about bamlanivimab came Wednesday from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response.
The announcement only applies to bamlanivimab used alone. It can still be used in combination with etesevimab, which is another monoclonal antibody.
CNN reported that the government has sent out nearly 800,000 doses bamlanivimab as of March 2.
“Given the sustained increase in SARS-CoV-2 viral variants in the United States that are resistant to bamlanivimab administered alone, and the availability of other authorized monoclonal antibody therapies that are expected to retain activity to these variants, the U.S. Government, in coordination with Eli Lilly and Company will stop the distribution of bamlanivimab alone,” the statement said.
The statement also said that the Food and Drug Administration (FDA) has updated its guidance on bamlanivimab, advising health care providers to consider alternative authorized monoclonal antibodies that can withstand circulating variants.
In a statement to The Hill, Eli Lilly said, “We recognize the U.S. government has made the decision to no longer allow direct ordering of bamlanivimab alone due to concerns about the prevalence of the California (B.1.427/B.1.429) and New York (B.1.526) variants of SARS-CoV-2.”
“Lilly developed bamlanivimab and etesevimab for administration together to be prepared for the spread of SARS-CoV-2 variants that could resist treatment with either monoclonal antibody alone,” the statement said. “We believe that sites with access to bamlanivimab and etesevimab for administration together should use that therapy over bamlanivimab alone.”
White House reviews whether to lift intellectual property shield on Covid vaccines – CNBC
- The White House is weighing whether to temporarily lift intellectual property protections on Covid-19 vaccines and treatments.
- The move would allow other countries to replicate existing vaccines.
- Concerns have grown about the fact that the U.S. and a handful of other wealthy countries hold the right to a disproportionate amount of the global supply.
The C.D.C.’s ex-director offers no evidence in favoring speculation that the coronavirus originated in a lab. – New York Times
The former director of the Centers for Disease Control and Prevention said in a CNN clip on Friday that he favored a theory, decried by many scientists and rejected as “extremely unlikely” by at least one World Health Organization international expert, that the coronavirus escaped from a lab in Wuhan. The former official, Dr. Robert Redfield, offered no evidence and emphasized that it was his opinion.
“I am of the point of view that I still think the most likely etiology of this pathogen in Wuhan was from a laboratory, escaped. The other people don’t believe that. That’s fine. Science will eventually figure it out,” Dr. Redfield told Dr. Sanjay Gupta in the video clip, referring to the origin of the virus. A formal report from the W.H.O. team and the Chinese scientists it worked with, on the origins of the pandemic and on the coronavirus in humans, is expected next week.
Despite Dr. Redfield’s comments, officials briefed on the intelligence say there is no new evidence that would cause American spy agencies to reassess their views. There is no new information that bolsters the so-called lab theory, according to officials briefed on the intelligence.
Could an accident have caused COVID-19? Why the Wuhan lab-leak theory shouldn’t be dismissed – USA Today
As members of a World Health Organization expert team have made international headlines recently dismissing as “extremely unlikely” the possibility that a laboratory accident in Wuhan, China, could have sparked the COVID-19 pandemic, I can’t stop thinking of the hundreds of lab accidents that are secretly occurring just in the United States.
As an investigative reporter, I have spent more than a decade revealing shocking safety breaches that officials at laboratories in our own country don’t want the public to know about.
I have uncovered exotic and deadly bacteria that have hitched rides out of high-security labs on workers’ dirty clothing, silently spreading contagion for weeks. I have revealed how spacesuit-like protective gear and tubes carrying safe oxygen to scientists have torn or broken – repeatedly – and high-tech safety systems have failed dramatically. Vials of viruses and bacteria have gone missing. Researchers bitten by infected lab animals have been allowed to move about in public – rather than being quarantined – while waiting for signs of infection to appear.
These and similar safety lapses are happening with disturbing regularity at elite U.S. labs operated by government agencies, the military, universities and private firms. There is no reason to believe they aren’t happening at labs in other countries as well.
The notion that more than 2.7 million deaths worldwide – so far – could be the result of a lab accident has been met with skepticism and derision by many journalists and scientists who often portray it as a crackpot conspiracy theory fueled by former President Donald Trump’s China-bashing rhetoric. Without question, the lab-leak theory has been politically and racially weaponized in ugly ways. Nonetheless, that rhetoric needs to be separated from legitimate questions about lab safety that are deserving of investigation.
Science, like journalism, is supposed to be about facts and about getting to the truth. But those who dare seek answers to reasonable questions about any lab accidents in Wuhan are accused of peddling conspiracies.
The following are foreign headlines with hyperlinks to the posts
Novel molecule could offer a new way to fight against SARS coronavirus 2
‘Alarm Bells’: Brazil’s COVID-19 Chaos Sparks Fear, Countermeasures From Neighbors
Peru Hits New COVID Case Record as Brazilian Variant Spreads
Mexico closes Yucatan tourist site due to surge of maskless visitors
WHO asks rich countries to donate 10 million vaccine doses to poorer ones
More vaccine production sites have been approved in the E.U. to aid with recent vaccine shortfalls.
Kenya imposes sharp restrictions on Nairobi and surrounding counties as a surge builds.
The following additional national and state headlines with hyperlinks to the posts
Alaska considers offering travelers vaccines at airport
How COVID-19 affects the brain
Latino Californians are among hardest hit by COVID-19
Infected Saliva May Be Pushing COVID Through the Body: Study
Pentagon: More troops that initially rejected COVID-19 vaccine now taking it
Medical students have had to adapt to remote cadaver dissections.
More than 100 cases of Covid-19 linked to outbreak at Nebraska child care facility
Today’s Posts On Econintersect Showing Impact Of The Pandemic With Hyperlinks
How COVID-19 Has Impacted Stock Performance By Industry
The Future Of Asia: What A Difference A Year Can Make
Jobless Claims Drop To Pandemic Low
Warning to Readers
The amount of politically biased articles on the internet continues to increase. And studies and opinions of the experts continue to contradict other studies and expert opinions. Honestly, it is difficult to believe anything anymore.
I assemble this coronavirus update daily – sifting through the posts on the internet. I try to avoid politically slanted posts (mostly from CNN, New York Times, and the Washington Post) and can usually find unslanted posts on that subject from other sources on the internet. I wait to publish posts on subjects that I cannot validate across several sources. But after all this extra work, I do not know if I have conveyed the REAL facts. It is my job to provide information so that you have the facts necessary – and then it is up to readers to draw conclusions.
Analyst Opinion of Coronavirus Data
There are several takeaways that need to be understood when viewing coronavirus statistical data:
- The global counts are suspect for a variety of reasons including political. Even the U.S. count has issues as it is possible that as much as half the population has had coronavirus and was asymptomatic. It would be a far better metric using a random sampling of the population weekly. In short, we do not understand the size of the error in the tracking numbers.
- Just because some of the methodology used in aggregating the data in the U.S. is flawed – as long as the flaw is uniformly applied – you establish a baseline. This is why it is dangerous to compare two countries as they likely use different methodologies to determine who has (and who died) from coronavirus.
- COVID-19 and the flu are different but can have similar symptoms. For sure, COVID-19 so far is much more deadly than the flu. [click here to compare symptoms]
- From an industrial engineering point of view, one can argue that it is best to flatten the curve only to the point that the health care system is barely able to cope. This solution only works if-and-only-if one can catch this coronavirus once and develops immunity. In the case of COVID-19, herd immunity may need to be in the 80% to 85% range. WHO warns that few have developed antibodies to COVID-19 when recovering from COVID-19. Herd immunity does not look like an option without immunization although there is now a discussion of whether T-Cells play a part in immunity [which means one might have immunity without antibodies]
- Older population countries will have a significantly higher death rate as there is relatively few hospitalizations and deaths in younger age groups..
- There are at least 8 strains of the coronavirus. California and New York may have a deadlier strain imported from Europe, compared to less deadly viruses elsewhere in the United States.
- Each publication uses different cutoff times for its coronavirus statistics. Our data uses 11:00 am London time. Also, there is an unexplained variation in the total numbers both globally and in the U.S.
What we do or do not know about the coronavirus [actually there is little scientifically proven information]. Most of our knowledge is anecdotal, from studies with limited subjects, or from studies without peer review.
- How many people have been infected as many do not show symptoms?
- Masks do work. Unfortunately, early in the pandemic, many health experts — in the U.S. and around the world — decided that the public could not be trusted to hear the truth about masks. Instead, the experts spread a misleading message, discouraging the use of masks.
- Current thinking is that we develop at least 5 months of immunity from further COVID infection.
- The Moderna and Pfizer vaccines have an effectiveness rate of about 95 percent after two doses. That is on par with the vaccines for chickenpox and measles. The 95 percent number understates the effectivenessas it counts anyone who came down with a mild case of Covid-19 as a failure. But turning Covid into a typical flu — as the vaccines evidently did for most of the remaining 5 percent — is actually a success. Of the 32,000 people who received the Moderna or Pfizer vaccine in a research trial, only one contracted a severe Covid case.
- To what degree do people who never develop symptoms contribute to transmission? Research early in the pandemic suggested that the rate of asymptomatic infections could be as high as 81%. But a meta-analysis, which included 13 studies involving 21,708 people, calculated the rate of asymptomatic presentation to be 17%.
- The accuracy of rapid testing is questioned – and the more accurate test results are not being given in a timely manner.
- Can children widely spread coronavirus? [current thinking is that they are a minor source of the pandemic spread]
- Why have some places avoided big coronavirus outbreaks – and others hit hard?
- Air conditioning contributes to the pandemic spread.
- It appears that there is increased risk of infection and mortality for those living in larger occupancy households.
- Male patients have almost three times the odds of requiring intensive treatment unit (ITU) admission compared to females.
- Outdoor activities seem to be a lower risk than indoor activities.
Treatments with solid scientific support:
- Dexamethasone
- Proning, or turning someone on their stomach
- Remdesivir
- Baricitinib
Treatments with potential but limited evidence:
- ECMO, or extracorporeal membrane oxygenation
- fluvoxamine
- Cyclosporine
- Famotidine
- Intravenous immunoglobulin
- Ivermectin
- Interferons
Drugs shown to be ineffective:
- The combination of lopinavir-ritonavir
- Hydroxychloroquine
- Insulin
- High dose zinc and vitamin C
- Convalescent plasma
- Monoclonal antibodies
- Tocilizumab
- Anti-coagulants
- A current scientific understanding of the way the coronavirus works can be found [here].
There is now a vaccine available – the questions remain:
- will there be any permanent side effects that will appear months from now,
- how long immunity will last [we can currently say we do not know if it will last more than 4 months],
- there is no solid evidence yet the vaccine will block transmission
Heavy breakouts of coronavirus have hit farmworkers. Farmworkers are essential to the food supply. They cannot shelter at home. Consider:
- they have high rates of respiratory disease [occupational hazard]
- they travel on crowded buses chartered by their employers
- few have health insurance
- they cannot social distance and live two to four to a room – and they eat together
- some reports say half are undocumented
- they are low paid and cannot afford not to work – so they will go to work sick
- they do not have access to sanitation when working
- a coronavirus outbreak among farmworkers can potentially shutter entire farm
The bottom line is that COVID-19 so far has been shown to be much more deadly than the data on the flu. Using CDC data, the flu has a mortality rate between 0.06 % and 0.11 % Vs. the coronavirus which to date has a mortality rate of 4 % [the 4% is the average of overall statistics – however in the last few months it has been hovering around 1.0%] – which makes it between 10 and 80 times more deadly. The reason for ranges:
Because influenza surveillance does not capture all cases of flu that occur in the U.S., CDC provides these estimated ranges to better reflect the larger burden of influenza.
There will be a commission set up after this pandemic ends to find fault [it is easy to find fault when a once-in-a-lifetime event occurs] and to produce recommendations for the next time a pandemic happens. Those that hate President Trump will conclude the virus is his fault.
Resources:
- Get the latest public health information from CDC: https://www.coronavirus.gov .
- Get the latest research from NIH: https://www.nih.gov/coronavirus.
- Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/.
- List of studies: https://icite.od.nih.gov/covid19/search/#search:searchId=5ee124ed70bb967c49672dad
include(“/home/aleta/public_html/files/ad_openx.htm”); ?>